These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2766368

  • 1. [Detection of hCG serum levels in choriocarcinoma using monoclonal antibodies].
    Vlachová J, Zavadil M, Jakoubková J, Skrivan J, Minajev G.
    Cesk Gynekol; 1989 Apr; 54(3):179-84. PubMed ID: 2766368
    [Abstract] [Full Text] [Related]

  • 2. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA, Hussa RO.
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [Abstract] [Full Text] [Related]

  • 3. Identification of epitopes associated with hCG and the beta hCG carboxyl terminus by monoclonal antibodies produced against a synthetic peptide.
    Bidart JM, Ozturk M, Bellet DH, Jolivet M, Gras-Masse H, Troalen F, Bohuon CJ, Wands JR.
    J Immunol; 1985 Jan; 134(1):457-64. PubMed ID: 2578049
    [Abstract] [Full Text] [Related]

  • 4. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 5. Determination of hCG in choriocarcinoma using RIA kits for hCG and hCG-beta.
    Vlachová J, Růzková M, Jakoubková J, Skrivan J, Zavadil M.
    Acta Univ Palacki Olomuc Fac Med; 1981 Feb; 101():166-71. PubMed ID: 6211046
    [No Abstract] [Full Text] [Related]

  • 6. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G, Pürstner P.
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [Abstract] [Full Text] [Related]

  • 7. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA, Khanlian SA, Muller CY, Giddings A, Kohorn E, Berkowitz R.
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [Abstract] [Full Text] [Related]

  • 8. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA, Butler S.
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [Abstract] [Full Text] [Related]

  • 9. Studies of monoclonal antibodies against human chorionic gonadotropin. II. Applications of human chorionic gonadotropin monoclonal antibodies on immunoassays.
    Chow SN, Hsieh CY, Ouyang PC, Leung WY, Ho-Yuen B, Lee CY.
    Diagn Immunol; 1986 Jun; 4(4):194-200. PubMed ID: 3530599
    [Abstract] [Full Text] [Related]

  • 10. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA, Sutton JM.
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [Abstract] [Full Text] [Related]

  • 11. [The hook effect as a cause of falsely lowered beta-HCG values].
    Dahlmann N.
    Dtsch Med Wochenschr; 1989 Jan 06; 114(1):36-7. PubMed ID: 2463141
    [No Abstract] [Full Text] [Related]

  • 12. [Monoclonal antibodies against the beta subunit of human chorionic gonadotropin].
    Fidler R, Sokolov AV, Verbitskiĭ MSh, Papazov IP.
    Biull Eksp Biol Med; 1988 Dec 06; 106(12):693-5. PubMed ID: 2462933
    [Abstract] [Full Text] [Related]

  • 13. Discordant human chorionic gonadotropin results: causes and solutions.
    Hussa RO, Rinke ML, Schweitzer PG.
    Obstet Gynecol; 1985 Feb 06; 65(2):211-9. PubMed ID: 3969234
    [Abstract] [Full Text] [Related]

  • 14. Use of an immunoradiometric assay and a radioimmunoassay for the detection of free beta-human chorionic gonadotropin.
    Shapiro AI, Wu TF, Ballon SC, Lamb EJ.
    Obstet Gynecol; 1985 Apr 06; 65(4):545-9. PubMed ID: 2580254
    [Abstract] [Full Text] [Related]

  • 15. [Monitoring hCG and its subunits in patients with choriocarcinoma].
    Vlachová J, Skrivan J, RůzkováM, Jakoubková J, Zavadil M, Polák J.
    Cesk Gynekol; 1984 Sep 06; 49(8):559-63. PubMed ID: 6209023
    [No Abstract] [Full Text] [Related]

  • 16. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA, Khanlian SA, Giddings A, Butler SA, Muller CY, Hammond C, Kohorn E.
    Gynecol Oncol; 2006 Aug 06; 102(2):165-72. PubMed ID: 16631243
    [Abstract] [Full Text] [Related]

  • 17. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations.
    Rotmensch S, Cole LA.
    Lancet; 2000 Feb 26; 355(9205):712-5. PubMed ID: 10703803
    [Abstract] [Full Text] [Related]

  • 18. Evaluation and clinical application of the quantitative radioreceptor assay for serum hCG.
    Boyko WL, Russell HT.
    Obstet Gynecol; 1979 Dec 26; 54(6):737-45. PubMed ID: 514561
    [Abstract] [Full Text] [Related]

  • 19. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN, Csaba IF, Bohn H, Szabó DG, Szalmásy M, Menczer G.
    Oncodev Biol Med; 1982 Dec 26; 3(4):315-23. PubMed ID: 6291007
    [Abstract] [Full Text] [Related]

  • 20. Phantom hCG and phantom choriocarcinoma.
    Cole LA.
    Gynecol Oncol; 1998 Nov 26; 71(2):325-9. PubMed ID: 9826481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.